Regulatory Open Forum

 View Only

Molecular Diagnostics in China: A Growth Industry

  • 1.  Molecular Diagnostics in China: A Growth Industry

    Posted 16-Feb-2018 17:11

    Molecular diagnostics plays an important role in Reprogenetics and Oncology, which has attracted more attention from the public than ever before.


    Keep up to date with CFDA changes and subscribe to our weekly CFDA News Roundup. Click HERE or email info@chinameddevice.com

    In China, there are about 16 million new births in China in 2017 with a very high infertility rate approximately 16%. The Preimplantation Genetic Diagnosis (PGD) cost about ¥16,000 (around $2,524). Nationally, the PGD market has a value of ¥10,4 billion ($1.64 billion). Because of technology barrier and a limited number of local manufacturers (noticeably Beijing Genomics Institute and Berry Genomics), the established and reputable foreign equipment manufacturers in the space can expect to have tremendous growth opportunities in the China market.

    Next-Generation Sequencing (NGS) for cancer treatment and Noninvasive Prenatal Testing (NIPT) have become commercially viable in China while the after treatment and early detection still have more room to grow. Illumina and Life Medical are the frontrunners of foreign sequencing equipment manufacturers in China.

    It is estimated that CFDA will impose more regulations on equipment and assay manufacturers of PGD, NGS and NIPT as well as allowing External Quality Assessment in the molecular diagnostics industry.

     

    Keep yourself updated with the weekly CFDA News Roundup, click HERE to opt-in. We also publish market access monthly newsletter, click HERE

     

    For more detailed information or English version of the documents, please contact us at info@ChinaMedDevice.com

     

    About China Med Device, LLC

    We provide turn-key solutions for western medical device/IVD companies to enter China with regulatory and commercialization services. Our CFDA regulatory services cover strategy, premarket submission, clinical evaluation, CRO, post market compliance as well as legal agent representation. Our management team in Boston and Beijing have processed 1,200+ certificates. Email info@ChinaMedDevice.com or visit www.ChinaMedDevice.com



    ------------------------------
    Grace Fu Palma
    China Med Device, LLC
    MA, U.S.
    gpalma@chinameddevice.com
    978-390-4453
    www.chinameddevice.com
    ------------------------------